Recovery Of Bone And Muscle Mass In Patients With Chronic Kidney Disease And Iron Overload On Hemodialysis And Taking Combined Supplementation With Curcumin And Resveratrol

References

• Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010;91(4):1128S–1132S. doi:10.3945/ajcn.2010.28608B20181807
   PubMed Web of Science ®Google Scholar
• Sahin K, Pala R, Tuzcu M, et al. Curcumin prevents muscle damage by regulating NF-kB and Nrf2 pathways and improves performance: an in vivo model. J Inflamm Res. 2016;9:147–154. doi:10.2147/JIR.S11087327621662
   PubMed Web of Science ®Google Scholar
• George L, Asghar M, Lokhandwala MF. Exercise activates redox-sensitive transcription factors and restores renal D1 receptor function in old rats. Am J Physiol Renal Physiol. 2009;297(5):F1174–F1180. doi:10.1152/ajprenal.00397.200919759268
   PubMed Web of Science ®Google Scholar
• Ali S, Mann DA. Signal transduction via the NFkB pathway: a targeted treatment modality for infection, inflammation and repair. Cell Biochem Funct. 2004;22(2):67–79. doi:10.1002/cbf.108215027095
   PubMed Web of Science ®Google Scholar
• Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115:3318–3325. doi:10.1172/JCI2707116322775
   PubMed Web of Science ®Google Scholar
• Jilka RL, O’Brien CA. The role of osteocytes in age-related bone loss. Curr Osteoporos Rep. 2016;14:16–25. doi:10.1007/s11914-016-0297-026909563
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhai W, Zhao M, et al. Effects of iron overload on the bone marrow microenvironment in mice. PLoS One. 2015;10(3):e0120219. doi:10.1371/journal.pone.012021925774923
   PubMed Web of Science ®Google Scholar
• Balogh E, Tolnai E, Nagy BJ, et al. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochim Biophys Acta. 2016;1862(9):1640–1649. doi:10.1016/j.bbadis.2016.06.00327287253
   PubMed Web of Science ®Google Scholar
• Durbin SM, Jackson JR, Ryan MJ, Gigliotti JC, Alway SE, Tou JC. Resveratrol supplementation influences bone properties in the tibia of hindlimb-suspended mature fisher 344 x Brown Norway male rats. Appl Physiol Nutr Metab. 2012;37:1179–1188. doi:10.1139/h2012-09923050779
   PubMed Web of Science ®Google Scholar
• Shakibaei M 1, Shayan P, Busch F, et al. Resveratrol mediated modulation of SIRT-1/RUNX2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of RUNX2 deacetylation. PLoS One. 2012;7:e35712. doi:10.1371/journal.pone.003571222539994
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. Aaps J. 2013;15(1):195–218. doi:10.1208/s12248-012-9432-823143785
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin,a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283–299. doi:10.1111/j.1440-1681.2011.05648.x22118895
   PubMed Web of Science ®Google Scholar
• Bharti AC, Takada Y, Aggarwal BB. Curcumin (diferuloylmethane) inhibits receptor activator of NF-Kappa B ligand-induced NF-Kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol. 2004;172:5940–5947.15128775
   PubMed Web of Science ®Google Scholar
• Hie M, Yamazaki M, Tsukamoto I. Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin- induce diabetes. Eur J Pharmacol. 2009;621(1–3):1–9. doi:10.1016/j.ejphar.2009.08.02519699734
   PubMed Web of Science ®Google Scholar
• Rohanizadeh R, Deng Y, Verron E. Therapeutic actions of curcumin in bone disorders. Bonekey Rep. 2016;5. doi:10.1038/bonekey.2016.20
   Google Scholar
• Folwarczna J, Zych M, Treciak HI. Effects of curcumin on the skeletal system in rats. Pharmacol Rep. 2010;62:900–909. doi:10.1016/S1734-1140(10)70350-921098873
   PubMed Web of Science ®Google Scholar
• Riva A, Togni S, Giacomelli L, et al. Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study. Eur Rev Med Pharmacol Sci. 2017;21:1684–1689.28429336
   PubMed Web of Science ®Google Scholar
• Fröjdö S 1, Durand C, Molin L, et al. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by sirt1. Mol Cell Endocrinol. 2011;335:166–276. doi:10.1016/j.mce.2011.01.00821241768
   PubMed Web of Science ®Google Scholar
• Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology. 2006;76(2):69–75. doi:10.1159/00008972016286809
   PubMed Web of Science ®Google Scholar
• Kim DH, Jung YJ, Lee JE, et al. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol. 2011;301(2):F427–F435. doi:10.1152/ajprenal.00258.201021593185
   PubMed Web of Science ®Google Scholar
• Soares TJ, Volpini RA, Francescato HDC, Costa RS, da Silva CGA, Coimbra TM. Effects of resveratrol on glicerol-induced acute renal failure in rat kidney. Life Sci. 2007;81(8):647–656. doi:10.1016/j.lfs.2007.06.03217698148
   PubMed Web of Science ®Google Scholar
• Chander V, Chopra K. Protective effect of resveratrol,a polyphenolic phytoalexin on gentamicin-induced acute renal failure in rat kidney. Ren Fail. 2006;28(2):161–169. doi:10.1080/0886022050053111216538975
   PubMed Web of Science ®Google Scholar
• Morales AI, Buitrago JM, Santiago JM, Fernández-Tagarro M, López-Novoa JM, Pérez- Barriocanal F. Protective effect of trans-resveratrol on gentamicin-induced nephrotoxcicity. Antioxid Redox Signal. 2002;4(6):893–898. doi:10.1089/15230860276219743412573138
   PubMed Web of Science ®Google Scholar
• Silan C, Uzun O, Comunoglu NU, Gokcen S, Bedirhan S, Ceniz M. Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol Pharm Bull. 2007;30(1):79–83. doi:10.1248/bpb.30.7917202664
   PubMed Web of Science ®Google Scholar
• Chander V, Tirkey N, Chopra K. Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology. 2005;210(1):55–64. doi:10.1016/j.tox.2005.01.01115804458
   PubMed Web of Science ®Google Scholar
• Sun LJ, Sun YN, Chen SJ, Liu S, Jiang GR. Resveratrol attenuates skeletal muscle atrophy induced by chronic kidney disease via MuRF1 signaling pathway. Biochem Biophys Res Commun. 2017;487(1):83–89. doi:10.1016/j.bbrc.2017.04.02228392400
   PubMed Web of Science ®Google Scholar
• Holthoff JH, Woodling KA, Doerge DR, Burns ST, Hinson JA, Mayeux PR. Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite. Biochem Pharmacol. 2010;80(8):1260–1265. doi:10.1016/j.bcp.2010.06.02720599800
   PubMed Web of Science ®Google Scholar
• Wang DT, Yin Y, Yang YJ, et al. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes. Int Immunopharmacol. 2014;19(2):206–213. doi:10.1016/j.intimp.2014.02.00224534773
   PubMed Web of Science ®Google Scholar
• Xiaonan H, Wang H, Mitch WE. Muscle wasting from kidney failure a model for catabolic conditions. Int J Biochem Cell Biol. 2013;45(10):2230–2238. doi:10.1016/j.biocel.2013.06.02723872437
   PubMed Web of Science ®Google Scholar
• Tisdale MJ. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol. 2005;3(3):209–217.15915823
   PubMedGoogle Scholar
• Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and survival in hemodialysis patients. Kidney Int. 1998;54(1):236–244. doi:10.1046/j.1523-1755.1998.00981.x9648084
   PubMed Web of Science ®Google Scholar
• Fanzani A, Conraads VM, Penna F, Martinet W. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle. 2012;3(3):163–179. doi:10.1007/s13539-012-0074-622673968
   PubMed Web of Science ®Google Scholar
• Resmi H. The combination of bortezomib and resveratrol may prevent muscle wasting in diabetes. Med Hypotheses. 2011;76(2):291–292. doi:10.1016/j.mehy.2010.10.02621051155
   PubMed Web of Science ®Google Scholar
• Attaix D, Ventadour S, Taillandier D, Combaret L. The ubiquitin-proteasome pathway: limitations and opportunities. Support Oncol. 2005;3(3):221–222.
   Google Scholar
• Carrero JJ, Chmielewski M, Axelsson J, et al. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr. 2008;27:557–564. doi:10.1016/j.clnu.2008.04.00718538898
   PubMed Web of Science ®Google Scholar
• Ornstrup MJ 1, Harslof T, Kjær TN, et al. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. J Clin Endocrinol Metab. 2014;99(12):4720–4729. PMID: 25322274. doi:10.1210/jc.2014-279925322274
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang Y, Wang Z, Xu Z, Zhang Q, Yin M. Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. J Nutr Biochem. 2015;26(11):1174–1182. doi:10.1016/j.jnutbio.2015.05.00926239832
   PubMed Web of Science ®Google Scholar
• Zaky A, Bassiouny A, Farghaly M, Bassma M. A combination of resveratrol and curcumin is effective against aluminum chloride- induced neuroinflammation in rats. J Alzheimers Dis. 2017;60(1):S221–S235. doi:10.3233/JAD-16111528222524
   PubMed Web of Science ®Google Scholar
• Tarantino G, Vinciguerra M, Ragosta A, et al. Do transferrin levels predict haemodialysis adequacy in patients with end-stage renal disease? Nutrients. 2019;11:1123. doi:10.3390/nu11051123
   Web of Science ®Google Scholar